Furthermore, KDM4A-AS1, a tumor promoter, was considerably enhanced in both cell lines and cancer tissues in castration-resistant prostate cancer (CRPC), whereas KDM4A-AS1 deletion dramatically lowered cell viability, in vitro proliferation, migration, and in vivo tumor growth (38). Here, KDM4A is linked to cancer.